Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial.
暂无分享，去创建一个
W. Ichikawa | R. Matoba | M. Fujii | K. Nakagawa | H. Hayashi | Masazumi Takahashi | R. Kawabata | H. Kawakami | Tasuku Honjo | J. Matsuyama | Y. Sunakawa | K. Chamoto | A. Ishiguro | Y. Akamaru | Y. Sakamoto | Y. Kito | H. Yabusaki | A. Makiyama | K. Noda | E. Inoue | Toshiyuki Sato | C. Suminaka | Mami Yamaki